Multiple Myeloma
Latest News in Multiple Myeloma
October 14, 2024
October 14, 2024
Johnson & Johnson receives updated NICE recommendation for Tecvayli in multiple myeloma – PMLiVE
October 14, 2024
Mitigating AEs and Protecting QOL Following Talquetamab in Multiple Myeloma – Cancer Network
October 14, 2024
677 Active Multiple Myeloma Clinical Trials
677 Active Multiple Myeloma Clinical Trials
As of October 8, 2024
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS
BROWSE
FDA-approved DRUGS